Compugen Ltd. (CGEN) — Analyst outlook / Analyst consensus target is. Based on 13 analyst ratings, the consensus is bullish — 12 Buy, 1 Sell.
The consensus price target is $4.00, representing an upside of 38.4% from the current price $2.89.
Analysts estimate Earnings Per Share (EPS) of $-0.07 and revenue of $0.04B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.16 vs est $-0.07 (missed -128.6%). 2025: actual $0.38 vs est $-0.30 (beat +226.7%). Analyst accuracy: 0%.
CGEN Stock — 12-Month Price Forecast
$4.00
▲ +38.41% Upside
Average Price Target
Based on 13 Wall Street analysts offering 12-month price targets for Compugen Ltd., the price target is $4.00.
The average price target represents a +38.41% change from the last price of $2.89.
CGEN Analyst Ratings
Buy
Based on 13 analysts giving stock ratings to Compugen Ltd. in the past 3 months
EPS Estimates — CGEN
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.16
vs Est –$0.07
▼ 56.3% off
2025
Actual $0.38
vs Est –$0.30
▲ 178.9% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving.
Revenue Estimates — CGEN
37%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.028B
vs Est $0.038B
▼ 34.9% off
2025
Actual $0.073B
vs Est $0.007B
▲ 90.3% off
Revenue Trend
Strong revenue growth over the period shown. Analysts forecast revenue contraction ahead.
